首页
关于GMP1001
实战案例
NAI GMP1001
文章详情
ICHM多学科(Multidisciplinary Guidelines)
2024-04-20
多学科(Multidisciplinary Guidelines)
序号
英文题目
中文译文
阶段
发布时间
是否有中文译稿
1
M1 MedDRA Terminology 监管活动医学词典
MedDRA Points to Consider Companion Document
MedDRA
®
数据检索和展示: 考虑要点
2018.06
有
MedDRA Term Selection: Points to Consider
MedDRA
®
术语选择: 考虑要点
2018.09.01
有
MedDRA Best Practices
MedDRA
®
最佳规范
2018
有
2
M2 Electronic Standards 电子标准
M2:Electronic Standards for the Transfer of Regulatory Information Final Concept Paper
M2:监管信息电子传输标准 最终概念文件
1994.10.27
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI) General Recommendation - Procedure
监管信息电子传输标准 一般性建议-程序
2015.6.11
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI)-Gateway
监管信息电子传输标准 一般性建议-ESTRI网关
2015.6.11
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI) File Format Recommendation – PDF
监管信息电子传输标准 文件格式建议-PDF
2011.4.5
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI) File Format Recommendation – XML
监管信息电子传输标准 文件格式建议-XML
2005.11.10
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI) File Format Recommendation – PDF/A
监管信息电子传输标准 文件格式建议-PDF/A
2014.6.2
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI)File Format Recommendation – DOCX
监管信息电子传输标准 文件格式建议-DOCX
2015.6.11
有
Electronic Standards for the Transfer of Regulatory Information Controlled Vocabularies Recommendation - Genericode
监管信息电子传输标准 受控词汇建议-通用编码
2015.6.11
有
Electronic Standards for the Transfer of Regulatory Information Information Transfer Recommendation – EDIINT V3.0
监管信息电子传输标准 信息传输建议-EDIINT V3.0
2018.6.7
有
Electronic Standards for the Transfer of Regulatory Information (ESTRI) File Integrity – MD5
监管信息电子传输标准 文件完整性-MD5
2010.6.10
有
Electronic Standards for the Transfer of Regulatory Informaation (ESTRI) File Integrity Recommendation - SHA-256
监管信息电子传输标准 文件完整性建议-SHA-256
2015.6.11
有
M2:Glossary of Terms and Abbreviations
M2:术语和缩略语词汇表
2015.6.11
有
M2:File Format Criteria
M2:文件格式标准
2014.11.10
有
Use of OIDs & UUIDs in ICH Messages
OID和UUID在ICH消息中的应用
2015.6.11
有
3
M3 Nonclinical Safety Studies 非临床研究
M3(R2) Questions and Answers (R2)
M3(R2)问答 (R2)
阶段5
2012.3.5
有
M3(R2): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
M3(R2):支持药物进行临床试验和上市的非临床安全性研究指导原则
阶段5
2009.6.11
有
4
M4 : The Common Technical Document 通用技术文件
M4 (R4): Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use
M4(R4):人用药物注册通用技术文档的组织(中文版:征求意见稿)
阶段5
2016.6.15
有
M4 Implementation Working Group Questions & Answers (R3)
M4执行工作组问答(R3)(中文版:征求意见稿)
阶段5
2004.6.10
有
The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality – M4Q(R1)
M4Q(R1):人用药物注册通用技术文档:药学部分(中文版:征求意见稿)
阶段5
2002.9.12
有
M4Q Implementation Working Group Questions & Answers (R1)
M4Q执行工作组问答(R1)(中文版:征求意见稿)
阶段5
2003.7.17
有
The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Safety – M4S(R2)
M4S(R2):人用药物注册通用技术文档:安全性部分(中文版:征求意见稿)
阶段5
2002.12.20
有
M4S Implementation Working Group Questions & Answers (R4)
M4S执行工作组问答 (R4)(中文版:征求意见稿)
阶段5
2003.11.11
有
Efficacy- M4E(R2)
M4E(R2):人用药物注册通用技术文档:有效性部分(中文版:征求意见稿)
阶段5
2016.6.15
有
M4E Implementation Working Group Questions & Answers (R4)
M4E执行工作组问答(R4)(中文版:征求意见稿)
阶段5
2004.6.10
有
5
M5 Data Elements and Standards for Drug Dictionaries 药物词典的数据要素和标准
The Re-development of the Standard for E2B(R3) and the Development of Standards for the Identification of Medicinal Products (IDMP)(ICH M5)
ICH M5: E2B(R3)标准的再制定及医药产品鉴定标准的制定
2010.11.1
ICH E2B(R3) Implementation Working Group ICH E2B(R3) Guideline: Electronic Transmission of Individual Case Safety Reports (ICSRs)
E2B(R3)实施工作组 个例病例安全报告的电子传输 问答部分
2.0版本
2016.11.10
Appendix I (B) to the Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs)
个例病例安全报告的电子传输实施指南附录 I (B)
2.02版本
2016.11.10
Appendix I (G) to the Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs)
个例病例安全报告的电子传输实施指南附录 I (G)
1.02版本
2016.11.10
Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs)
个例病例安全报告的电子传输实施指南
5.02版本
2016.11.10
6
M6 Gene Therapy 基因治疗
Final Concept Paper M6: Guideline on Virus and Gene Therapy Vector Shedding and Transmission
M6: 病毒和基因治疗载体的脱落和传播 终版概念文件
2009.8.26
General Principles to Address Virus and Vector Shedding
解决病毒和基因治疗载体脱落的基本原则
2009.6
An inventory of shedding data from clinical gene therapy trials
临床基因疗法试验脱落数据目录
2007.7.30
Final Business Plan M6: Guideline on Virus and Gene Therapy Vector Shedding and Transmission
M6: 病毒和基因治疗载体的脱落和传播 终版业务计划
2009.8.27
7
M7 Genotoxic Impurities 遗传毒性杂质
M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
M7:评估和控制药物中的DNA活性(致突变)杂质以限制潜在的致癌风险
阶段5
2014.6.23
有
M7(R1): Addendum to M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
M7(R1):评估和控制药物中DNA反应性(致突变)杂质以限制潜在致癌风险
阶段5
2017.3.31
有
M7(R2):Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
M7(R2):评估和控制药物中DNA反应性(致突变)杂质以限制潜在致癌风险
阶段5
2023.4.3
有
M7(R2):Questions and Answers
M7(R2):问答文件
阶段5
2022.5.24
有
Addendum to M7(R2) :Application of The Principles of the ICH M7 Guideline to Calculation of Compound-Specific Acceptable Intakes
M7(R2)附录:ICH M7原则在化合物可接受摄入量计算中的应用
阶段5
2023.4.3
有
8
M8 Electronic Common Technical Document (eCTD) 电子通用技术文件
Electronic Common Technical Document Specification V3.2.2
电子通用技术文件规范 V3.2.2
2008.7.16
M8 : Electronic Common Technical Document Concept Paper
M8: 电子通用技术文件 概念文件
2015.12.9
ICH M8 EWG/IWG Work Plan
M8: 电子通用技术文件 工作计划
2017.3.13
Support Documentation for M8: eCTD EWG eCTD v4.0 Implementation Package v1.2
M8:eCTD专家工作组eCTD v4.0实施包 v1.2 支持性证明文件
2016.11
Orientation Material forM8: eCTD EWG eCTD v4.0 Implementation Package v1.2
M8:eCTD专家工作组eCTD v4.0实施包 v1.2 培训材料
2016.11
ICH Electronic Common Technical Document (eCTD) v4.0 Implementation Guide v1.2
ICH eCTD v4.0 实施指南 v1.2
2016.11.10
eCTD v4.0 Implementation Package v1.2
eCTD v4.0 实施包 v1.2
USFDA eCTD v4.0 Implementation Package History v1.1
美国FDA eCTD v4.0 实施包历史 v1.1
USFDA Module 1 Electronic Common Technical Document (eCTD) v4.0 Implementation Guide v1.1
美国FDA 模块1 eCTD v4.0 实施指南 v1.1
2017.2.20
ICH eCTD v4.0 Requirements
ICH eCTD v4.0 要求
ICH M8 Expert Working Group Specification for Submission Formats for eCTD
eCTD提交格式规范
2016.11.10
Change Control Process for the eCTD
eCTD变更控制过程
2017.4
Request for change
请求变更表
9
M9 Biopharmaceutics Classification System-based Biowaivers 基于生物药剂学分类系统的生物豁免
M9: Biopharmaceutics Classification System-based Biowaivers
M9:基于生物药剂学分类系统的生物等效性豁免
阶段5
2019.11.20
有
M9 Questions and Answers
M9问答文件
阶段5
2019.11.20
有
10
M10 Bioanalytical Method Validation and Study Sample Analysis 生物分析方法验证及样品分析
M10 Bioanalytical Method Validation and Study Sample Analysis
M10:生物分析方法验证及样品分析
阶段5
2022.05.24
有
M10 Questions and Answers(Q&As)
M10问答文件
阶段5
2022.11.16
有
M10 Frequently Asked Questions (FAQs)
M10常见问题解答文件
阶段5
2022.11.11
有
DMF/NDC注册
阅读69
分享
下一篇:
这是最后一篇
上一篇:
这是第一篇
写评论...
发表评论
登录评论
匿名评论
提交
提交